WFA
HUMA icon

Wipfli Financial Advisors’s Humacyte HUMA Stock Holding History

Wipfli Financial Advisors’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1K Buy
+200
New +$767 ﹤0.01% 2429

Other funds holding HUMA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wipfli Financial Advisors's HUMA Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Humacyte (HUMA) in Q3 2022: 200 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2429 among its holdings.

70 funds tracked by Wall St. Rank hold HUMA as of Q3 2022.

  • Wipfli Financial Advisors held 200 shares of Humacyte worth $1K as of Q3 2022.
  • Humacyte was a new Wipfli Financial Advisors position in Q3 2022.
  • Humacyte made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2429 holding.
  • 70 funds tracked by Wall St. Rank held Humacyte as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.